Investors Look Past Weak Second Quarter
Allscripts Healthcare Solutions reported a big drop in profits, but guidance was strong. Full-year profit is expected to be $0.77 to $0.83, up from an earlier forecast of $0.74 to $0.80. Revenue also beat the Street. MDRX rallies 12 percent before the bell on my tradeMONSTER platform.
Monster Beverage Misses On Weak Pricing
Monster Beverage reported second quarter profit of $0.59 a share on revenue of $592.6 million. Analysts had expected $0.61 and $592.16 million, respectively. The main reason for the miss was lower prices per case sold, which hurt margins. MNST drops 4 percent in the premarket.
Elizabeth Arden' Earnings And Revenue Beat
Elizabeth Arden earned $0.28 a share, beating the $0.20 consensus estimate. Revenue of $265.5 million also exceeded the $263.83 forecast by analysts. Guidance was better than expected as well, and RDEN is up 15 percent in early trading.
